Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Chemomab Therapeutics Ltd. | 20,497 | reported | 16 Jun 2023 | tx 2+20,497 |
| Passage BIO, Inc. | 3,729 | reported | 08 Dec 2021 | tx 9+406,774−73,275 |
| Terns Pharmaceuticals, Inc. | 0 | reported | 05 May 2026 | tx 32+261,874−290,349 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 45,000 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 10,657 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 32,000 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 3,955 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 22,000 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 32,000 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 1,697 | — | deriv |
| 01 Feb 2026 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 1,697 | 0.00 USD | deriv |
| 04 Nov 2025 | SALE | Terns Pharmaceuticals, Inc. | 24,520 | 18.00 USD | |
| 04 Nov 2025 | EXERCISE | Terns Pharmaceuticals, Inc. | 24,520 | 9.24 USD | |
| 04 Nov 2025 | EXERCISE | Terns Pharmaceuticals, Inc. | 24,520 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 45,000 | 0.00 USD | deriv |
| 01 Feb 2025 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 10,657 | 0.00 USD | deriv |
| 06 Jan 2025 | SALE | Terns Pharmaceuticals, Inc. | 8,760 | 5.79 USD | |
| 02 Jan 2025 | SALE | Terns Pharmaceuticals, Inc. | 6,240 | 5.72 USD | |
| 09 Sept 2024 | SALE | Terns Pharmaceuticals, Inc. | 17,235 | 10.00 USD | |
| 09 Sept 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 17,235 | 1.82 USD | |
| 09 Sept 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 17,235 | 0.00 USD | deriv |
| 01 Aug 2024 | SALE | Terns Pharmaceuticals, Inc. | 6,143 | 7.68 USD | |
| 02 Aug 2024 | SALE | Terns Pharmaceuticals, Inc. | 8,857 | 7.50 USD | |
| 15 Jul 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 14,365 | 1.82 USD | |
| 15 Jul 2024 | SALE | Terns Pharmaceuticals, Inc. | 14,365 | 10.00 USD | |
| 16 Jul 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 400 | 1.82 USD | |
| 16 Jul 2024 | SALE | Terns Pharmaceuticals, Inc. | 400 | 10.00 USD | |
| 16 Jul 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 400 | 0.00 USD | deriv |